CUV 10.8% $17.77 clinuvel pharmaceuticals limited


  1. 375 Posts.
    lightbulb Created with Sketch. 14
    There has been numerous articles and talk from all over the world on Epitans discovery and potential-refer to and click onto ept for postings. Furthermore to all this publicity, I have been informed Wayne Millen (Chief Exec.) has been interviewed by 60 minutes in America. This will be screened in the USA in Nov. The yanks are really excited about Epitans potential earnings (remember drug discovered in USA and high profile directors based there)
    Will be huge one day (especially when the rest of the world is talking about it) and people can visualize the skin changing colour.

    Some Facts:
    -Phase 1 trials successful
    -Phase 2 trials to be announced within weeks
    -High profile dermotoligist and skin cancer specialist Prof. Cooper on board
    -Ex. CSL Managing Dir. on board recently appointed
    -Major overseas bioteh companies have shown strong interest for joint venture arrangements

    It's only a matter of time before we see big things from this stock. Patients is the key.
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Mkt cap ! $878.0M
Open High Low Value Volume
$18.90 $19.09 $17.64 $11.55M 628.0K

Buyers (Bids)

No. Vol. Price($)
1 276 $17.77

Sellers (Offers)

Price($) Vol. No.
$17.90 400 1
View Market Depth
Last trade - 16.10pm 28/02/2020 (20 minute delay) ?
-2.160 ( 10.8 %)
Open High Low Volume
$18.76 $19.09 $17.67 50583
Last updated 15.59pm 28/02/2020 (live) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.